Shopping Cart 0
Cart Subtotal
AED 0

Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Osiris Therapeutics Inc (OSIR)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Osiris Therapeutics Inc (Osiris) is a regenerative medicine company. It researches, develops and markets regenerative medicine products. The company developed the world's first approved stem cell drug. It offers products in wound care, orthopedics, and sports medicine market. Osiris develops products based on BioSmart, a proprietary process for tissue and cell preservation that maintains integrity of the biological materials. Osiris, Grafix, Stravix and Cartiform are trademarks of Osiris. The company continues to advance its research and development (R&D) in biotechnology by focusing on innovation in regenerative medicine including stem cell research, bioengineering and viable tissue based products. Osiris is headquartered in Columbia, Maryland, the US.

Osiris Therapeutics Inc Key Recent Developments

Nov 07,2018: Osiris Therapeutics reports third quarter 2018 results

Oct 03,2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation

Oct 03,2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation

Oct 02,2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues

Jun 04,2018: Osiris Announces Implementation of Prestige Lyotechnology Preservation Method Allowing Ambient Storage of Living Tissues

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Osiris Therapeutics Inc-Key Facts 6

Osiris Therapeutics Inc-Key Employees 7

Osiris Therapeutics Inc-Key Employee Biographies 8

Osiris Therapeutics Inc-Major Products and Services 9

Osiris Therapeutics Inc-History 10

Osiris Therapeutics Inc-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Company Overview 14

Osiris Therapeutics Inc-Business Description 15

Osiris Therapeutics Inc-Corporate Strategy 16

Osiris Therapeutics Inc-SWOT Analysis 17

SWOT Analysis-Overview 17

Osiris Therapeutics Inc-Strengths 17

Osiris Therapeutics Inc-Weaknesses 18

Osiris Therapeutics Inc-Opportunities 19

Osiris Therapeutics Inc-Threats 20

Osiris Therapeutics Inc-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's, Lifesciences Financial Deals and Alliances 28

Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Osiris Therapeutics Inc, Recent Deals Summary 30

Section 5-Company's Recent Developments 31

Nov 07, 2018: Osiris Therapeutics reports third quarter 2018 results 31

Oct 03, 2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation 32

Oct 03, 2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation 33

Oct 02, 2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues 34

Jun 04, 2018: Osiris Announces Implementation of Prestige Lyotechnology Preservation Method Allowing Ambient Storage of Living Tissues 35

Feb 06, 2018: Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO 36

Oct 23, 2017: Osiris Announces a Peer-Reviewed Publication of a Scientific Study Reporting Antimicrobial Properties of Human Cryopreserved Viable Amniotic Membrane 37

Oct 19, 2017: Osiris Therapeutics to Present 10 Advanced Clinical and Scientific Abstracts, Including an Exclusive Oral Presentation on its New Ambient Viable Tissue Preservation Technology 38

Jun 26, 2017: Osiris Appoints Linda Palczuk to serve as its President & CEO 39

May 31, 2017: Osiris Appoints David White to its Board of Directors 40

Section 6-Appendix 41

Methodology 41

Ratio Definitions 41

About GlobalData 45

Contact Us 45

Disclaimer 45


List Of Figure

List of Figures

Osiris Therapeutics Inc, Performance Chart (2013-2017) 25

Osiris Therapeutics Inc, Ratio Charts 27

Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29


List Of Table

List of Tables

Osiris Therapeutics Inc, Key Facts 6

Osiris Therapeutics Inc, Key Employees 7

Osiris Therapeutics Inc, Key Employee Biographies 8

Osiris Therapeutics Inc, Major Products and Services 9

Osiris Therapeutics Inc, History 10

Osiris Therapeutics Inc, Subsidiaries 13

Osiris Therapeutics Inc, Key Competitors 21

Osiris Therapeutics Inc, Ratios based on current share price 22

Osiris Therapeutics Inc, Annual Ratios 23

Osiris Therapeutics Inc, Annual Ratios (Cont...1) 24

Osiris Therapeutics Inc, Interim Ratios 26

Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Osiris Therapeutics Inc, Recent Deals Summary 30

Currency Codes 41

Capital Market Ratios 41

Equity Ratios 42

Profitability Ratios 42

Cost Ratios 43

Liquidity Ratios 43

Leverage Ratios 44

Efficiency Ratios 44

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Osiris Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Vericel Corp

Symic Biomedical Inc

MultiCell Technologies Inc

MiMedx Group Inc

Microbot Medical Inc

Geron Corp

Cytori Therapeutics Inc

CymaBay Therapeutics Inc

Cellerant Therapeutics Inc

Athersys Inc

Astellas Institute for Regenerative Medicine

Osiris Therapeutics Inc (OSIR)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Osiris Therapeutics Inc (Osiris) is a regenerative medicine company. It researches, develops and markets regenerative medicine products. The company developed the world's first approved stem cell drug. It offers products in wound care, orthopedics, and sports medicine market. Osiris develops products based on BioSmart, a proprietary process for tissue and cell preservation that maintains integrity of the biological materials. Osiris, Grafix, Stravix and Cartiform are trademarks of Osiris. The company continues to advance its research and development (R&D) in biotechnology by focusing on innovation in regenerative medicine including stem cell research, bioengineering and viable tissue based products. Osiris is headquartered in Columbia, Maryland, the US.

Osiris Therapeutics Inc Key Recent Developments

Nov 07,2018: Osiris Therapeutics reports third quarter 2018 results

Oct 03,2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation

Oct 03,2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation

Oct 02,2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues

Jun 04,2018: Osiris Announces Implementation of Prestige Lyotechnology Preservation Method Allowing Ambient Storage of Living Tissues

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Osiris Therapeutics Inc-Key Facts 6

Osiris Therapeutics Inc-Key Employees 7

Osiris Therapeutics Inc-Key Employee Biographies 8

Osiris Therapeutics Inc-Major Products and Services 9

Osiris Therapeutics Inc-History 10

Osiris Therapeutics Inc-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Company Overview 14

Osiris Therapeutics Inc-Business Description 15

Osiris Therapeutics Inc-Corporate Strategy 16

Osiris Therapeutics Inc-SWOT Analysis 17

SWOT Analysis-Overview 17

Osiris Therapeutics Inc-Strengths 17

Osiris Therapeutics Inc-Weaknesses 18

Osiris Therapeutics Inc-Opportunities 19

Osiris Therapeutics Inc-Threats 20

Osiris Therapeutics Inc-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's, Lifesciences Financial Deals and Alliances 28

Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Osiris Therapeutics Inc, Recent Deals Summary 30

Section 5-Company's Recent Developments 31

Nov 07, 2018: Osiris Therapeutics reports third quarter 2018 results 31

Oct 03, 2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation 32

Oct 03, 2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation 33

Oct 02, 2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues 34

Jun 04, 2018: Osiris Announces Implementation of Prestige Lyotechnology Preservation Method Allowing Ambient Storage of Living Tissues 35

Feb 06, 2018: Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO 36

Oct 23, 2017: Osiris Announces a Peer-Reviewed Publication of a Scientific Study Reporting Antimicrobial Properties of Human Cryopreserved Viable Amniotic Membrane 37

Oct 19, 2017: Osiris Therapeutics to Present 10 Advanced Clinical and Scientific Abstracts, Including an Exclusive Oral Presentation on its New Ambient Viable Tissue Preservation Technology 38

Jun 26, 2017: Osiris Appoints Linda Palczuk to serve as its President & CEO 39

May 31, 2017: Osiris Appoints David White to its Board of Directors 40

Section 6-Appendix 41

Methodology 41

Ratio Definitions 41

About GlobalData 45

Contact Us 45

Disclaimer 45


List Of Figure

List of Figures

Osiris Therapeutics Inc, Performance Chart (2013-2017) 25

Osiris Therapeutics Inc, Ratio Charts 27

Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29


List Of Table

List of Tables

Osiris Therapeutics Inc, Key Facts 6

Osiris Therapeutics Inc, Key Employees 7

Osiris Therapeutics Inc, Key Employee Biographies 8

Osiris Therapeutics Inc, Major Products and Services 9

Osiris Therapeutics Inc, History 10

Osiris Therapeutics Inc, Subsidiaries 13

Osiris Therapeutics Inc, Key Competitors 21

Osiris Therapeutics Inc, Ratios based on current share price 22

Osiris Therapeutics Inc, Annual Ratios 23

Osiris Therapeutics Inc, Annual Ratios (Cont...1) 24

Osiris Therapeutics Inc, Interim Ratios 26

Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Osiris Therapeutics Inc, Recent Deals Summary 30

Currency Codes 41

Capital Market Ratios 41

Equity Ratios 42

Profitability Ratios 42

Cost Ratios 43

Liquidity Ratios 43

Leverage Ratios 44

Efficiency Ratios 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Osiris Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Vericel Corp

Symic Biomedical Inc

MultiCell Technologies Inc

MiMedx Group Inc

Microbot Medical Inc

Geron Corp

Cytori Therapeutics Inc

CymaBay Therapeutics Inc

Cellerant Therapeutics Inc

Athersys Inc

Astellas Institute for Regenerative Medicine